Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
21.73
+0.32 (1.49%)
At close: Nov 10, 2026, 4:00 PM EST
21.10
-0.63 (-2.90%)
After-hours: Nov 10, 2026, 7:59 PM EST
Structure Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $90 | Buy | Maintains | $90 | +314.17% | Nov 10, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $93 | Buy | Maintains | $93 | +327.98% | Nov 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $111 → $107 | Buy | Reiterates | $111 → $107 | +392.41% | Nov 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +222.14% | Sep 9, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $104 | Buy | Maintains | $104 | +378.60% | Sep 8, 2026 |
| Jefferies | Jefferies | Buy Maintains $125 | Buy | Maintains | $125 | +475.24% | Sep 8, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 8, 2026 |
| Clear Street | Clear Street | Buy Maintains $99 | Buy | Maintains | $99 | +355.59% | Sep 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.